# Fujimori et al. (2007) Study on the Effects of Bifidobacterium breve and Lactobacillus casei in Patients with Mild to Moderate Crohn's Disease

Unfortunately, I could not access the full text of the study. However, based on the information provided, the study found that treatment with Bifidobacterium breve and Lactobacillus casei led to a significant decrease in the Crohn's Disease Activity Index (CDAI) and an improvement in the quality of life for patients with mild to moderate Crohn's disease.